Todd P. Branning is Chief Financial Officer of NeuBase Therapeutics Inc.
Person profile
Roles
NeuBase Therapeutics
Chief Financial Officer
Address
Bridgewater, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NeuBase Therapeutics, Inc.
17 Mar 23
4
NeuBase Therapeutics, Inc.
4 Nov 22
4
NeuBase Therapeutics, Inc.
21 Mar 22
4
NeuBase Therapeutics, Inc.
18 Mar 22
4
NeuBase Therapeutics, Inc.
10 Jan 22
3
NeuBase Therapeutics, Inc.
10 Jan 22
4
Phathom Pharmaceuticals, Inc.
29 Jan 21
4
Phathom Pharmaceuticals, Inc.
13 Jul 20
3
Phathom Pharmaceuticals, Inc.
13 Jul 20
4
Amneal Pharmaceuticals, Inc.
2 Mar 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Mar 23 | NBSE NeuBase Therapeutics | Common stock | Grant | Acquire A | No | No | 0 | 54,200 | 0.00 | 84,200 |
3 Nov 22 | NBSE NeuBase Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 0.28 | 200,000 | 56.00 k | 200,000 |